These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28600709)

  • 1. Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.
    Piromkraipak P; Sangpairoj K; Tirakotai W; Chaithirayanon K; Unchern S; Supavilai P; Power C; Vivithanaporn P
    Cell Mol Neurobiol; 2018 Mar; 38(2):559-573. PubMed ID: 28600709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
    Piromkraipak P; Parakaw T; Phuagkhaopong S; Srihirun S; Chongthammakun S; Chaithirayanon K; Vivithanaporn P
    Can J Physiol Pharmacol; 2018 Aug; 96(8):798-806. PubMed ID: 29726704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.
    Woszczek G; Chen LY; Alsaaty S; Nagineni S; Shelhamer JH
    J Immunol; 2010 Feb; 184(4):2219-25. PubMed ID: 20083671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
    Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
    Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Migration and Invasion Effects of Astaxanthin against A172 Human Glioblastoma Cell Line.
    Siangcham T; Vivithanaporn P; Sangpairoj K
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2029-2033. PubMed ID: 32711429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review.
    Sood R; Anoopkumar-Dukie S; Rudrawar S; Hall S
    Eur J Pharmacol; 2024 Sep; 978():176755. PubMed ID: 38909933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
    Di Gennaro A; Araújo AC; Busch A; Jin H; Wågsäter D; Vorkapic E; Caidahl K; Eriksson P; Samuelsson B; Maegdefessel L; Haeggström JZ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1907-1912. PubMed ID: 29432192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.
    Mohamed MZ; Zenhom NM
    Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells.
    Suknuntha K; Yubolphan R; Krueaprasertkul K; Srihirun S; Sibmooh N; Vivithanaporn P
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):833-837. PubMed ID: 29582642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    Langlois A; Ferland C; Tremblay GM; Laviolette M
    J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells.
    Virchow JC; Faehndrich S; Nassenstein C; Bock S; Matthys H; Luttmann W
    Clin Exp Allergy; 2001 Jun; 31(6):836-44. PubMed ID: 11422147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression
    Chen Y; Zhang J; Wei S
    Curr Pharm Biotechnol; 2023; 24(10):1335-1342. PubMed ID: 36503460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
    Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
    Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
    Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS
    Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cough, asthma, and cysteinyl-leukotrienes.
    Niimi A
    Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.